Eduardu Martin

Eduardo San Martín Suñol is a private-capital investment professional identified in SpainCap/ASCRI directories as part of the GED Iberian Private Equity investment team. The 2017 ASCRI annual directory listed him as “Director de Inversiones” at GED Iberian Private Equity, using the email prefix `[hidden]`; the 2020 ASCRI directory again listed him as “Director de Inversiones” on GED’s investment team.

GED Capital was founded in 1996 and later rebranded as Buenavista Equity Partners in October 2024. The firm describes itself as an independent private-capital manager focused on the lower/mid-market, with vehicles across Private Equity, Venture Capital and Infrastructure. Buenavista says it manages around €1 billion on its main website and more than €1.3 billion in its July 2026 Buyout III announcement.

A French official education record lists Eduardo San Martin Sunol among École nationale des ponts et chaussées engineering diploma recipients for the 2005 cohort, with the decree published on 17 July 2007. I did not find a current firm biography, public headshot, or verified LinkedIn profile for him.

Public market-profile data also connects Eduardo San Martín Suñol with Beka Asset Management SGIIC SA / Private Equity, but the available source did not provide a current title or enough detail to treat that as his primary current role.

• GED/Buenavista’s private equity strategy targets lower/mid-market companies and aims to transform them into sector leaders through growth and consolidation strategies.
• Buenavista states that its buyout funds seek majority equity stakes in companies with EBITDA above €3 million and operating margins above 15%.
• The firm’s preferred buyout verticals are industrial companies, consumer goods with emphasis on the food value chain, and healthcare products and services.
• Buenavista says its buyout portfolios typically hold 7–10 companies and do not exceed €30 million per transaction.
• The Healthcare Growth strategy invests mainly minority stakes “with a lead investor mindset,” focusing on healthcare companies at or near commercialization and primarily in the Iberian Peninsula.
• Buenavista’s stated value-creation levers include organic growth, buy-and-build acquisitions, professionalization of management teams, digitalization, ESG policies, operational support, and financial optimization.
• The firm says proprietary deal flow is important: its team and industrial network generate transactions across buyouts, venture capital and infrastructure, and proprietary deal flow represents more than two-thirds of total deal flow.